Lung Cancers Unknown Status Phase 2 Trials for Irinotecan (DB00762)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIITreatment
NCT00616785Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTreatment
NCT00465907Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTreatment